Delivery Order SPE2DB24D2100-SPE2DB25FBBXB
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NEUPOGEN 300 MCG/ML vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The contract has a ceiling value of $1,242.31 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $1,214.78, for the supply of NEUPOGEN 300 MCG/ML VIALML. This medical product is likely used to support military healthcare programs. The contract has a period of performance through February...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFY23, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order valued at $6,931.66, is for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
The federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $1,521.95 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp has...
This federal contract award is for pharmaceutical and medical supplies provided by Amerisourcebergen Drug Corp, the prime contractor, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $1,164.26 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award is for the supply of pharmaceutical and medical products to support the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a ceiling value of $273,665.09 and is a Firm Fixed Price delivery order, with an ultimate completion date of September 13, 2024. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal healthcare providers. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to various government agencies. The contract has a ceiling value of $1,727.32 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This federal contract award is a delivery order valued at $2,241.90 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for medical products, including "INJECTOR DRG DLV BD PHASEAL IV LL N35 LF", with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...